ticlopidine has been researched along with Brittle Bone Disease in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajsadeghi, S | 1 |
| Jafarian Kerman, SR | 1 |
| Pouraliakbar, H | 1 |
| Mohammadi, R | 1 |
1 other study available for ticlopidine and Brittle Bone Disease
| Article | Year |
|---|---|
A huge coronary artery aneurysm in osteogenesis imperfecta: a case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Aneurysm; Drug Therap | 2012 |